Product image of Moxifloxacine Biogaran (Moxifloxacin) supplied by GNH India

Moxifloxacine Biogaran

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacine Biogaran (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacine Biogaran, is a fluoroquinolone antibiotic presented as an oral formulation for systemic use. It treats a range of bacterial infections, particularly respiratory and soft‑tissue infections, in adult patients. The drug works by inhibiting bacterial DNA replication, providing effective coverage against susceptible Gram‑negative and Gram‑positive organisms.

GNH India supplies Moxifloxacine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Manufacturer / TM Owner

Biogaran

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Moxifloxacine Biogaran is a fluoroquinolone antibiotic indicated for several bacterial infections.
  • Community‑acquired pneumonia: achieves bacterial clearance and clinical recovery.
  • Acute bacterial sinusitis: reduces sinus inflammation and eradicates causative pathogens.
  • Acute bacterial exacerbation of chronic bronchitis: improves airflow and resolves infection.
  • Skin and soft tissue infections: eliminates skin‑associated bacteria and promotes healing.
  • Complicated intra‑abdominal infections: provides broad‑spectrum coverage to control intra‑abdominal sepsis.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By stabilizing the enzyme‑DNA complex, it prevents DNA strand separation, halting bacterial DNA synthesis and transcription, which leads to bacterial cell death. This mechanism confers bactericidal activity against a wide range of Gram‑negative and Gram‑positive organisms.

Side Effects

Moxifloxacine Biogaran may cause a variety of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, sometimes watery.
  • Headache: transient cranial discomfort.
  • Dizziness: sensation of light‑headedness.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Tendon rupture: sudden tendon pain or rupture, especially Achilles.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Clostridioides difficile infection: severe colitis with watery diarrhea.
  • Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.

Precautions & Warnings

  • Before prescribing Moxifloxacine Biogaran, clinicians should consider several safety measures.
  • Assess renal function: adjust use in patients with impaired kidney function.
  • Monitor for tendon pain: discontinue if signs of tendonitis appear.
  • Avoid concomitant QT‑prolonging drugs: reduce risk of cardiac arrhythmias.
  • Use with caution in patients with known cardiac arrhythmias: monitor ECG as needed.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Moxifloxacine Biogaran can interact with several medications, requiring careful management.

Major Interactions (Avoid)

  • Other fluoroquinolones (e.g., ciprofloxacin): additive risk of tendon rupture.
  • Antacids containing magnesium or aluminum: reduce oral absorption of moxifloxacin.
  • Warfarin: may increase anticoagulant effect and bleeding risk.
  • CYP450 inducers (e.g., rifampicin): decrease plasma concentrations of moxifloxacin.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: heightened risk of tendon injury.
  • Theophylline: may raise theophylline plasma levels, causing toxicity.
  • Diabetes medications: potential alteration of glycemic control.

Frequently Asked Questions

Moxifloxacine Biogaran is indicated for adult patients with community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, skin and soft‑tissue infections, and complicated intra‑abdominal infections. It provides broad‑spectrum antibacterial activity against the typical pathogens involved in these conditions.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication and transcription. By preventing these processes, the drug stops bacterial cells from multiplying, leading to bacterial death and resolution of the infection.

The dosage of Moxifloxacine Biogaran is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Only a qualified healthcare professional can set the appropriate dose and treatment duration.

Safety data for moxifloxacin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician after careful assessment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers a broader spectrum against Gram‑positive organisms and better activity in respiratory infections compared with some older fluoroquinolones such as ciprofloxacin. Its pharmacokinetic profile allows once‑daily dosing, but safety considerations like QT prolongation remain similar across the class.

Store Moxifloxacine Biogaran at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Moxifloxacine Biogaran is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing magnesium or aluminum, which may interfere with absorption.

Serious risks include tendon rupture, especially in the Achilles tendon, QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be instructed to seek immediate medical attention if they experience related symptoms.

Moxifloxacine Biogaran is contraindicated in patients with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any of the product’s excipients. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone use or those with uncontrolled cardiac arrhythmias.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT